DETAILED ACTION
Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION. —The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claim 12 rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention.
It is unclear in claim 12 is the (TPO) in line 3 is an intended claim limitation or a descriptor?
Claim 12 contains the trademark/trade name TPO. Where a trademark or trade name is used in a claim as a limitation to identify or describe a particular material or product, the claim does not comply with the requirements of 35 U.S.C. 112(b). See Ex parte Simpson, 218 USPQ 1020 (Bd. App. 1982). The claim scope is uncertain since the trademark or trade name cannot be used properly to identify any particular material or product. A trademark or trade name is used to identify a source of goods, and not the goods themselves. Thus, a trademark or trade name does not identify or describe the goods associated with the trademark or trade name. In the present case, the trademark/trade name is used to identify/describe diphenyl(2,4,6-trimethyl(benzoyl)phosphine oxide and, accordingly, the identification/description is indefinite.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
Claim(s) 1-2, 7-9, 11, and 14-15 is/are rejected under 35 U.S.C. 102(a1) as being anticipated by Itai et al (7,173,072).
Itai sets forth radiation curable resin composition for forming optical parts. Said compositions comprise (A) 5-70 wt. % of a urethane (meth) acrylate; (B) 0.1 to 70 wt. % of a benzyl (meth)acrylate; and (C) 10-70 wt. % of an ethylenically unsaturated compound other than (A) or (B)see abstract. Additionally, said compositions comprise (D) a photoinitiator in amounts from 0.01 to 10 wt. %--see col. 6, lines 20-65.
Per example 5, Itai explicitly teaches a composition comprising 1 wt. % of resin A-2 (a urethane di(meth) acrylate; 14.1 wt. % of resin A-3 (a urethane di(meth)acrylate; 11.3 wt. % of resin A-5 (a urethane hexa/penta(meth) acrylate); 1.4 wt. % of benzyl acrylate; 22.5 wt. % of 4-ethylene oxide-modified phenoxy acrylate; 33.8 wt. % of ethylene oxide-modified p-cumylphenol acrylate; and 2.5 wt. % of a photoinitiator (I-184)—see example 5, Table 1.
Said composition comprises a combined wt. % of mono-functional aromatic (meth) acrylate having one aromatic ring (benzyl acrylate and phenoxy-4EO-acrylate) and mono-functional aromatic (meth) acrylate having two or more aromatic rings (EO-p-cumylphenol acrylate) of 57.7 wt. % of all the polymerizable compound in the composition. Said composition comprises a hexa/penta-functional urethane (meth) acrylate in an amount of 15.2 wt. % based on the total of all polymerizable compounds (claims 2 and 7). Said EO-p-cumylphenol acrylate has a biphenyl structure:
PNG
media_image1.png
203
362
media_image1.png
Greyscale
--(claim 8). The EO-p-cumylphenol acrylate has an ether modified structure (ethylene oxide)— claim 9. The I-184 anticipates claim 11. Park sets forth said cured composition of taught resin compositions are useful in optical parts, such for backlight of LCDs or screens for projection devices or backlight—see col. 1, lines 5-15 (claim14 and 15).
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability should not be negated by the manner in which the invention was made.
Claim(s) 4, 6, and 12 is/are rejected under 35 U.S.C. 103 as being unpatentable over Itai (cited above).
Itai is set forth above as anticipating the instantly claimed invention. The primary difference is Itai does not expressly set forth the properties of claims 4 and 6. However, it is deemed the composition is set forth in the examples and the tan delta is the balance between a material’s elastic and viscous responses and should be inherent to the composition. And since The Patent and Trademark Office are not equipped to conduct experimentation in order to determine whether Applicant’s composition differs and, if so, to what extent, from the discussed reference. Therefore, with the showing of the reference, the burden of establishing non-obviousness by objective evidence is shifted to the Applicants.
Itai does not expressly set forth the Tg; however, the is the temperature at which an amorphous material transitions from a hard, brittle "glassy" state to a softer, flexible "rubbery" state and should be inherent to the cured polymer resin. And since The Patent and Trademark Office are not equipped to conduct experimentation in order to determine whether Applicant’s composition differs and, if so, to what extent, from the discussed reference. Therefore, with the showing of the reference, the burden of establishing non-obviousness by objective evidence is shifted to the Applicants.
Regarding claim 12: Itai sets forth TPO is an equivalent photoinitiator useable in the composition—see col. 6, lines 41-42. Therefore, it would have been obvious for a skilled artisan to replace the photoinitiator I-184 in the example with the equivalently taught TPO with a reasonable expectation of obtaining a depth cure in absence of evidence to the contrary and/or unexpected results.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SANZA L MCCLENDON whose telephone number is (571)272-1074. The examiner can normally be reached 8-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Riviere-Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SANZA L. McCLENDON/Primary Examiner, Art Unit 1765
SMc